Fig. 3
From: Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer
Construction and validation of the NRG signature for OC. (A-C) Distribution of OC patients in high- and low-risk groups stratified by the NRG signature in the training, testing, and entire set. (D–F) Survival statuses of patients in different groups stratified by the NRG signature in the training, testing, and entire set. (G–I) Heatmap of two extracted NRGs expression in the training, testing, and entire set. (J-L) Kaplan–Meier survival analysis curves in the training, testing, and entire TCGA-OV set